Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma
Author:
Affiliation:
1. Department of Internal Medicine Cleveland Clinic Cleveland OH USA
2. Department of Hematology and Oncology Cleveland Clinic Taussig Cancer Institute Cleveland OH USA
Publisher
Wiley
Subject
Hematology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16454
Reference13 articles.
1. Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond
2. Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma.
3. Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14)
4. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
5. Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advancing the understanding of venetoclax in t(11;14)-positive multiple myeloma: a comprehensive review of clinical evidence and future prospects;Hematology;2023-12-27
2. Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14);Pathology and Oncology Research;2023-11-10
3. Advances in the management of myeloma: an update;British Journal of Nursing;2023-09-21
4. Venetoclaxalapú mentőkezelés (11;14)-transzlokációs myeloma multiplexben az első vonalbeli kezelésre adott nem megfelelő válasz esetén;Orvosi Hetilap;2023-06-11
5. Efficacy and safety of venetoclax-based regimens for the treatment of relapsed/refractory multiple myeloma: a systemic review and meta-analysis;Therapeutic Advances in Hematology;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3